SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve audited financial results ....
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Lifesciences India Ltd has informed BSE that its 93rd Board Meeting is scheduled for Thursday, May 29, 2025. The Board will consider and approve the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. It will also discuss recommending a dividend for FY 2024-25, if any, along with any other items the Board may decide. The trading window for designated persons and their immediate relatives remains closed till May 31, 2025, in line with SEBI insider trading rules. No actual financial numbers or outcomes are disclosed in this filing, which is a routine pre-results intimation under SEBI LODR Regulations 29 and 33.
Investors should watch May 29 closely — the audited FY25 results and any dividend declaration are likely to be the next catalysts for the stock. Until then, the stock remains in a quiet period with the trading window closed for insiders.